EIHSX Mutual Fund

NAV$14.00

Fund Essentials - as of May 31, 2026

Net Assets
$167M
Expense Ratio
0.93%
Dividend Yield (Current)
7.37%
Holdings
44
Inception Date
Oct 1, 2009
Fund Family
Eaton Vance
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD-0.58%
1 Year+11.08%
3 Year+5.47%
5 Year+4.15%
10 Year+8.51%

Asset Allocation

Stocks: 99.69%
Other: 0.31%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly And Company12.47%
ABBVAbbvie Inc Health Care6.46%
JNJJOHNSON AND JOHNSON6.45%
AZN:LNAstrazeneca Plc Adr6.24%
UNHUnited Health Group5.49%
Top 10 Concentration: 58.60%Report Date: May 31, 2026
Download all 44 holdings for EIHSX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
7.37%
Frequency
Annually
Latest Distribution
$1.24
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how EIHSX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

EIHSX Mutual Fund Overview

EIHSX Mutual Fund (Eaton Vance Worldwide Health Sciences Fund Class I) is managed by Eaton Vance with $167.1M in net assets. EIHSX expense ratio is 0.93%, holding 44 positions across sectors including Health Care, Unknown, Financials. Inception date: 2009-10-01.

EIHSX performance shows a YTD return of -0.58%. The 1-year return is 11.08% and the 5-year return is 4.15%. EIHSX dividend yield stands at 7.37%, paid annually.

EIHSX top holdings include Eli Lilly And Company (12.5%), Abbvie Inc Health Care (6.5%), JOHNSON AND JOHNSON (6.5%), Astrazeneca Plc Adr (6.2%), United Health Group (5.5%). View all EIHSX holdings, sector breakdown, or dividend history.

EIHSX can be compared against other funds using the overlap calculator or side-by-side comparison tool. EIHSX alternatives are available via the screener, along with tax-loss harvesting opportunities.